Fortis Healthcare Limited has informed the Exchange regarding 'Execution of Tripartite Agreement among Uttar Pradesh Industrial Development Authority (UPSIDA), R.R. Lifesciences Pvt Ltd and International Hospital Limited (IHL)'.
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Healthcare has informed the stock exchange that a tripartite agreement has been signed between the Uttar Pradesh Industrial Development Authority (UPSIDA), R.R. Lifesciences Pvt Ltd, and International Hospital Limited (IHL), a subsidiary of Fortis. The agreement is linked to a hospital project being set up in Uttar Pradesh, likely involving land allotment or infrastructure development through UPSIDA. IHL is the Fortis entity undertaking the hospital operations in the state. The arrangement brings in R.R. Lifesciences as another party alongside the government body and Fortis's hospital arm. No financial value or deal size has been disclosed in the filing.
This is a procedural/operational update related to Fortis's hospital expansion in Uttar Pradesh and is unlikely to have a meaningful short-term impact on the stock price. Shareholders should watch for further updates on project timelines, capacity, and any capital commitment tied to this agreement.